ROR1 and neoplasm: Daily i.v. infusion of MOPC21-IT (Figure 3f, blue line) or ROR1-IT (Figure 3f, red line) did not significantly influence body weight of tumor-bearing mice, but ROR1-IT completely halted tumor growth from HS-578T xenografts up to 3 weeks of treatment in NSG mice relative to control group (Figure 3g, p < 0.05, two-way ANOVA).